Proteomic Profiling of Ovarian Cancer Models Using TMT-LC-MS/MS
Herein, we have utilized two cellular models of epithelial ovarian cancer (EOC), where transfer of normal chromosome 18 material into the EOC cell lines TOV-112D and TOV-21G induced in vitro and in vivo suppression of tumorigenic phenotype in derived hybrid clones. Two-dimensional-liquid chromatography tandem mass spectrometry (2D-LC-MS/MS) with tandem mass tagging (TMT) was then employed to profile the whole cell, secreted and crude membrane proteomes of the parental and hybrid cell models to identify differentially expressed proteins as potential markers of ovarian tumor suppression. Protein changes of interest were confirmed by immunoblotting in additional hybrid and revertant cell lines. This method afforded quantitative coverage of around 1,000 unique proteins and is applicable to the analysis of any cell model, tissue or biofluid.
- Alterations in the Expression of Insulin-Like Growth Factors and Their Binding Proteins in Lung Cancer
- c-myb Antisense Oligonucleotide Therapeutics for Hematologic Malignancies
- Cancer Gene Profiling in Prostate Cancer
- nm23 Protein Expression by Western Blotting in Patients with Epithelial Ovarian Carcinoma
- Detection of Differentially Expressed Genes in Cancer Using Differential Display
- DNA Methylation in Pancreatic Cancer: Protocols for the Isolation of DNA and Bisulfite Modification
- Single Nucleotide Polymorphisms in DNA Repair Genes and Prostate Cancer Risk
- Tumor Deprivation of Oxygen and Tumor Suppressor Gene Function
- Reversing Agents for ATP-Binding Cassette Drug Transporters
- 用于组织工程研究的水凝胶三维包裹细胞法